AI English summary of an SEC filing — figures as filed
Illinois Tool Works ITWThe company said operating income for Q1 2025 was $951 million, a decrease of 15.6%, or 5.8% excluding the $117 million favorable impact of the LIFO accounting method change in Q1 2024. Operating margin was 24.8%, down 360 basis points.
Key points
AI summaryThe company said operating income for Q1 2025 was $951 million, a decrease of 15.6%, or 5.8% excluding the $117 million favorable impact of the LIFO accounting method change in Q1 2024. Operating margin was 24.8%, down 360 basis points.
The company said organic revenue for Q1 2025 decreased 1.6%. North America declined 3.3%, Europe, Middle East and Africa decreased 3.0%, and Asia Pacific increased 6.7%, while product line simplification activities reduced organic revenue by 50 basis points.
The company said diluted earnings per share for Q1 2025 was $2.38, a decrease of 12.8%, or 2.5% excluding the $0.29 favorable impact of the LIFO accounting method change in Q1 2024. The effective tax rate was 21.7%, which included a discrete tax benefit of $21 million.
The company repurchased approximately 1.5 million shares of its common stock in Q1 2025 for approximately $375 million. As of March 31, 2025, approximately $3.1 billion remained available under the $5.0 billion authorization under the 2023 program, and cash and cash equivalents were $873 million.
Key figures
Quarter ended March 31, 2025
- Revenue
- $3.8B
- Operating income
- $951M
- Net income
- $700M
- EPS
- $2.38
- Operating cash flow
- $592M
From the XBRL financial data filed with the SEC · not processed by AI.
Summary
AI-writtenAnalysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.
Q1 2025 Operating Income $951 million and Operating Margin 24.8%
The company said operating income for Q1 2025 was $951 million, a decrease of 15.6%, or 5.8% excluding the $117 million favorable impact of the LIFO accounting method change in Q1 2024. Operating margin was 24.8%, down 360 basis points.
Source · Based on the MD&A text of the filing
Q1 Organic Revenue Down 1.6%, Varied by Region
The company said organic revenue for Q1 2025 decreased 1.6%. North America declined 3.3%, Europe, Middle East and Africa decreased 3.0%, and Asia Pacific increased 6.7%, while product line simplification activities reduced organic revenue by 50 basis points.
Source · Based on the MD&A text of the filing
Q1 2025 Diluted Earnings Per Share $2.38
The company said diluted earnings per share for Q1 2025 was $2.38, a decrease of 12.8%, or 2.5% excluding the $0.29 favorable impact of the LIFO accounting method change in Q1 2024. The effective tax rate was 21.7%, which included a discrete tax benefit of $21 million.
Source · Based on the MD&A text of the filing
Q1 2025 Share Repurchases and Remaining Authorization
The company repurchased approximately 1.5 million shares of its common stock in Q1 2025 for approximately $375 million. As of March 31, 2025, approximately $3.1 billion remained available under the $5.0 billion authorization under the 2023 program, and cash and cash equivalents were $873 million.
Source · Based on the MD&A text of the filing
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…